Bridget E. Bunner

Array ( [id] => 5575424 [patent_doc_number] => 20090142786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/364329 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 63187 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142786.pdf [firstpage_image] =>[orig_patent_app_number] => 12364329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530280 [patent_doc_number] => 07842502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Use of CXCL6 chemokine for inducing precursor cells into chondrocytes' [patent_app_type] => utility [patent_app_number] => 12/345369 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8857 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842502.pdf [firstpage_image] =>[orig_patent_app_number] => 12345369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101773 [patent_doc_number] => 20110165265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'TRAIL VARIANTS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/808595 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 28336 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165265.pdf [firstpage_image] =>[orig_patent_app_number] => 12808595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10528211 [patent_doc_number] => 09254322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Compositions comprising E-selectin antagonists and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/747324 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 33378 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501680 [patent_doc_number] => 20090162368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'MECHANOSENSITIVE MAMMALIAN POTASSIUM CHANNEL ACTIVATABLE BY POLYUNSATURATED FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 12/329381 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 5588 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162368.pdf [firstpage_image] =>[orig_patent_app_number] => 12329381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062999 [patent_doc_number] => 20110200993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'NEW TREATMENT OF AUTOIMMUNE CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/743480 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8220 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200993.pdf [firstpage_image] =>[orig_patent_app_number] => 12743480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099817 [patent_doc_number] => 08563695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Antibodies that bind β2' [patent_app_type] => utility [patent_app_number] => 12/743516 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 44 [patent_no_of_words] => 28308 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498962 [patent_doc_number] => 20100209907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 12/265677 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30983 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209907.pdf [firstpage_image] =>[orig_patent_app_number] => 12265677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440979 [patent_doc_number] => 20090092618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/262284 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4750 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092618.pdf [firstpage_image] =>[orig_patent_app_number] => 12262284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546912 [patent_doc_number] => 20090156789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Compositions, Methods and Kits Useful for the Diagnosis and Treatment of Spinal Muscular Atrophy' [patent_app_type] => utility [patent_app_number] => 12/259141 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 58582 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156789.pdf [firstpage_image] =>[orig_patent_app_number] => 12259141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564617 [patent_doc_number] => 20090137470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHODS OF TREATING CANCER USING NOTCH PATHWAY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/245518 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12290 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137470.pdf [firstpage_image] =>[orig_patent_app_number] => 12245518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502244 [patent_doc_number] => 20090162932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'POLYPEPTIDE HAVING AN ACTIVITY TO SUPPORT PROLIFERATION OR SURVIVAL OF HEMATOPOIETIC STEM CELL OR HEMATOPOIETIC PROGENITOR CELL, AND DNA CODING FOR THE SAME' [patent_app_type] => utility [patent_app_number] => 12/239276 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17655 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162932.pdf [firstpage_image] =>[orig_patent_app_number] => 12239276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614418 [patent_doc_number] => 20100310504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'METHODS FOR TREATING FIBROSIS BY MODULATING CELLULAR SENESCENCE' [patent_app_type] => utility [patent_app_number] => 12/679835 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14977 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310504.pdf [firstpage_image] =>[orig_patent_app_number] => 12679835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5584987 [patent_doc_number] => 20090104189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/210134 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199223 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104189.pdf [firstpage_image] =>[orig_patent_app_number] => 12210134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5584987 [patent_doc_number] => 20090104189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/210134 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199223 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104189.pdf [firstpage_image] =>[orig_patent_app_number] => 12210134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336824 [patent_doc_number] => 20090053288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Hemostatic woven fabric' [patent_app_type] => utility [patent_app_number] => 12/228490 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7450 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053288.pdf [firstpage_image] =>[orig_patent_app_number] => 12228490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422000 [patent_doc_number] => 20090148455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Anti-RANTES antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/221485 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29411 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148455.pdf [firstpage_image] =>[orig_patent_app_number] => 12221485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62965 [patent_doc_number] => 07758857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Stimulation of hematopoiesis by ex vivo activated immune cells' [patent_app_type] => utility [patent_app_number] => 12/220989 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8839 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/758/07758857.pdf [firstpage_image] =>[orig_patent_app_number] => 12220989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309769 [patent_doc_number] => 20090017050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'EGFR ANTIGEN-BINDING MOLECULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/171889 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27826 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017050.pdf [firstpage_image] =>[orig_patent_app_number] => 12171889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452164 [patent_doc_number] => 20090068201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/170333 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 162736 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068201.pdf [firstpage_image] =>[orig_patent_app_number] => 12170333 [rel_patent_id] =>[rel_patent_doc_number] =>)